RND3 and ROCK1 |
Rho family GTPase 3 |
Rho-associated, coiled-coil containing protein kinase 1 |
|
- Signaling by GPCR
- Apoptotic cleavage of cellular proteins
- Axon guidance
- Semaphorin interactions
- Apoptotic execution phase
- VEGFA-VEGFR2 Pathway
- EPHB-mediated forward signaling
- EPHA-mediated growth cone collapse
- GPCR downstream signaling
- Signaling by VEGF
- Programmed Cell Death
- EPH-Ephrin signaling
- G alpha (12/13) signalling events
- Sema4D in semaphorin signaling
- Sema4D induced cell migration and growth-cone collapse
|
|
- HYDROXYFASUDIL
- (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE
- 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE
- (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE
|
|
|
RND3 and PLXNB1 |
Rho family GTPase 3 |
plexin B1 |
|
- Signaling by GPCR
- GPCR downstream signaling
- Axon guidance
- Semaphorin interactions
- G alpha (12/13) signalling events
- Sema4D mediated inhibition of cell attachment and migration
- Sema4D in semaphorin signaling
- Sema4D induced cell migration and growth-cone collapse
|
|
|
|
|
RND3 and UBXN11 |
Rho family GTPase 3 |
UBX domain protein 11 |
|
|
|
|
|
|
RND3 and UBC |
Rho family GTPase 3 |
ubiquitin C |
|
|
|
|
|
|
RHOG and ELMO1 |
ras homolog family member G |
engulfment and cell motility 1 |
- Signaling by GPCR
- Axon guidance
- Semaphorin interactions
- Rho GTPase cycle
- GPCR downstream signaling
- Signaling by Rho GTPases
- GPVI-mediated activation cascade
- G alpha (12/13) signalling events
- Sema4D in semaphorin signaling
- Platelet activation, signaling and aggregation
- Sema4D induced cell migration and growth-cone collapse
|
- Signaling by VEGF
- HIV Infection
- Host Interactions of HIV factors
- The role of Nef in HIV-1 replication and disease pathogenesis
- Fcgamma receptor (FCGR) dependent phagocytosis
- VEGFA-VEGFR2 Pathway
- Regulation of actin dynamics for phagocytic cup formation
- Innate Immune System
- Nef and signal transduction
|
|
|
|
|
ARHGAP1 and PTPN11 |
Rho GTPase activating protein 1 |
protein tyrosine phosphatase, non-receptor type 11 |
- Rho GTPase cycle
- Signaling by Rho GTPases
|
- Signaling by FGFR in disease
- Netrin mediated repulsion signals
- Signaling by EGFRvIII in Cancer
- Interferon gamma signaling
- Downstream signaling events of B Cell Receptor (BCR)
- Toll Like Receptor TLR1:TLR2 Cascade
- PI3K/AKT activation
- Toll Like Receptor 5 (TLR5) Cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- MyD88 dependent cascade initiated on endosome
- SOS-mediated signalling
- Prolactin receptor signaling
- SHC-mediated signalling
- PI3K Cascade
- TRIF-mediated TLR3/TLR4 signaling
- ERK1 activation
- ERK1 activation
- Spry regulation of FGF signaling
- Constitutive PI3K/AKT Signaling in Cancer
- Platelet sensitization by LDL
- Signaling by VEGF
- Signalling to RAS
- Toll Like Receptor 3 (TLR3) Cascade
- Downstream signal transduction
- Interleukin-2 signaling
- PI3K/AKT Signaling in Cancer
- Frs2-mediated activation
- Adaptive Immune System
- Axon guidance
- IRS-mediated signalling
- Interleukin-6 signaling
- VEGFA-VEGFR2 Pathway
- Activated TLR4 signalling
- GRB2 events in ERBB2 signaling
- VEGFR2 mediated cell proliferation
- PI3K events in ERBB2 signaling
- MyD88:Mal cascade initiated on plasma membrane
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- NCAM signaling for neurite out-growth
- Netrin-1 signaling
- RAF/MAP kinase cascade
- Signalling to p38 via RIT and RIN
- Innate Immune System
- Signaling by Insulin receptor
- Insulin receptor signalling cascade
- Interferon Signaling
- CTLA4 inhibitory signaling
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- SHC-related events
- Tie2 Signaling
- PECAM1 interactions
- Signaling by FGFR
- ARMS-mediated activation
- Nuclear signaling by ERBB4
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- PD-1 signaling
- PI3K Cascade
- Signaling by the B Cell Receptor (BCR)
- Signaling by GPCR
- FCERI mediated MAPK activation
- Signaling by SCF-KIT
- SHC1 events in ERBB2 signaling
- DAP12 signaling
- PI-3K cascade
- Toll Like Receptor 9 (TLR9) Cascade
- Negative regulation of FGFR signaling
- Signaling by PDGF
- DAP12 interactions
- Regulation of IFNA signaling
- GAB1 signalosome
- GRB2 events in EGFR signaling
- SHC-related events triggered by IGF1R
- Signal regulatory protein (SIRP) family interactions
- Signaling by ERBB4
- Role of LAT2/NTAL/LAB on calcium mobilization
- PI3K events in ERBB4 signaling
- Signaling by ERBB2
- Toll Like Receptor 2 (TLR2) Cascade
- Signaling by EGFR
- Signaling by Interleukins
- SHC1 events in ERBB4 signaling
- Platelet homeostasis
- Toll Like Receptor 4 (TLR4) Cascade
- Signaling by EGFR in Cancer
- Fc epsilon receptor (FCERI) signaling
- Interleukin-3, 5 and GM-CSF signaling
- Signaling by Leptin
- Signalling to ERKs
- Prolonged ERK activation events
- Costimulation by the CD28 family
- ERK activation
- PIP3 activates AKT signaling
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- IGF1R signaling cascade
- Toll Like Receptor TLR6:TLR2 Cascade
- Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
- IRS-related events triggered by IGF1R
- MyD88 cascade initiated on plasma membrane
- ERK activation
- Downstream signaling of activated FGFR
- Interferon alpha/beta signaling
- Signalling by NGF
- SOS-mediated signalling
- MAP kinase activation in TLR cascade
- SHC-mediated signalling
- Cytokine Signaling in Immune system
- NGF signalling via TRKA from the plasma membrane
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- MyD88-independent cascade
- Cell surface interactions at the vascular wall
- ERK2 activation
- SHC1 events in EGFR signaling
- IRS-mediated signalling
- FRS2-mediated cascade
- ERK2 activation
- Regulation of IFNG signaling
|
|
|
|
|
ARHGAP1 and SRC |
Rho GTPase activating protein 1 |
SRC proto-oncogene, non-receptor tyrosine kinase |
- Rho GTPase cycle
- Signaling by Rho GTPases
|
|
|
- Dasatinib
- RU84687
- RU79256
- N6-Benzyl Adenosine-5\'-Diphosphate
- RU85493
- RU78262
- Phosphonotyrosine
- Malonic acid
- RU83876
- RU90395
- RU79072
- RU78783
- 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
- PASBN
- RU82129
- PAS219
- DPI59
- RU82197
- Phenylphosphate
- RU78300
- RU79073
- RU82209
- ISO24
- RU85053
- RU78299
- Oxalic Acid
- RU78191
- Citric Acid
- RU81843
- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
- Purvalanol A
- Bosutinib
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
- 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
- N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
- [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
- 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
- N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
- (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- Ponatinib
|
|
|
ARHGAP4 and MAP3K1 |
Rho GTPase activating protein 4 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
- Rho GTPase cycle
- Signaling by GPCR
- GPCR downstream signaling
- Signalling by NGF
- Cell death signalling via NRAGE, NRIF and NADE
- Signaling by Rho GTPases
- NRAGE signals death through JNK
- G alpha (12/13) signalling events
- p75 NTR receptor-mediated signalling
|
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- FCERI mediated MAPK activation
- Toll Like Receptor TLR6:TLR2 Cascade
- Toll Like Receptor 2 (TLR2) Cascade
- Toll Like Receptor TLR1:TLR2 Cascade
- Activated TLR4 signalling
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Toll-Like Receptors Cascades
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 10 (TLR10) Cascade
- Toll Like Receptor 5 (TLR5) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- MyD88 dependent cascade initiated on endosome
- MyD88:Mal cascade initiated on plasma membrane
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- Fc epsilon receptor (FCERI) signaling
- TRAF6 mediated NF-kB activation
- Toll Like Receptor 9 (TLR9) Cascade
- Innate Immune System
|
|
|
|
|
ARL1 and GCC1 |
ADP-ribosylation factor-like 1 |
GRIP and coiled-coil domain containing 1 |
|
|
|
|
|
|
ARNT and SRC |
aryl hydrocarbon receptor nuclear translocator |
SRC proto-oncogene, non-receptor tyrosine kinase |
- Cellular response to hypoxia
- Regulation of Hypoxia-inducible Factor (HIF) by oxygen
- Regulation of gene expression by Hypoxia-inducible Factor
|
|
|
- Dasatinib
- RU84687
- RU79256
- N6-Benzyl Adenosine-5\'-Diphosphate
- RU85493
- RU78262
- Phosphonotyrosine
- Malonic acid
- RU83876
- RU90395
- RU79072
- RU78783
- 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
- PASBN
- RU82129
- PAS219
- DPI59
- RU82197
- Phenylphosphate
- RU78300
- RU79073
- RU82209
- ISO24
- RU85053
- RU78299
- Oxalic Acid
- RU78191
- Citric Acid
- RU81843
- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
- Purvalanol A
- Bosutinib
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
- 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
- N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
- [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
- 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
- N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
- (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- Ponatinib
|
|
|
ARR3 and SRC |
arrestin 3, retinal (X-arrestin) |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
|
|
- Dasatinib
- RU84687
- RU79256
- N6-Benzyl Adenosine-5\'-Diphosphate
- RU85493
- RU78262
- Phosphonotyrosine
- Malonic acid
- RU83876
- RU90395
- RU79072
- RU78783
- 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
- PASBN
- RU82129
- PAS219
- DPI59
- RU82197
- Phenylphosphate
- RU78300
- RU79073
- RU82209
- ISO24
- RU85053
- RU78299
- Oxalic Acid
- RU78191
- Citric Acid
- RU81843
- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
- Purvalanol A
- Bosutinib
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
- 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
- N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
- [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
- 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
- N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
- (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- Ponatinib
|
|
|
ARRB2 and AVPR2 |
arrestin, beta 2 |
arginine vasopressin receptor 2 |
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by Wnt
- beta-catenin independent WNT signaling
- Thrombin signalling through proteinase activated receptors (PARs)
- Activated NOTCH1 Transmits Signal to the Nucleus
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- Hedgehog 'on' state
- Signaling by NOTCH1
- WNT5A-dependent internalization of FZD4
- Signaling by Hedgehog
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Platelet activation, signaling and aggregation
- PCP/CE pathway
- Activation of SMO
- FBXW7 Mutants and NOTCH1 in Cancer
|
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- Vasopressin-like receptors
- G alpha (s) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Class A/1 (Rhodopsin-like receptors)
- Metabolic disorders of biological oxidation enzymes
- Aquaporin-mediated transport
- GPCR ligand binding
- GPCR downstream signaling
- Peptide ligand-binding receptors
|
|
- Desmopressin
- Vasopressin
- Conivaptan
- Terlipressin
- Tolvaptan
|
|
|
ARRB2 and TGFBR3 |
arrestin, beta 2 |
transforming growth factor, beta receptor III |
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by Wnt
- beta-catenin independent WNT signaling
- Thrombin signalling through proteinase activated receptors (PARs)
- Activated NOTCH1 Transmits Signal to the Nucleus
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- Hedgehog 'on' state
- Signaling by NOTCH1
- WNT5A-dependent internalization of FZD4
- Signaling by Hedgehog
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Platelet activation, signaling and aggregation
- PCP/CE pathway
- Activation of SMO
- FBXW7 Mutants and NOTCH1 in Cancer
|
|
|
|
|
|
ASAH1 and CAMK1D |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
calcium/calmodulin-dependent protein kinase ID |
- Sphingolipid metabolism
- Metabolism of lipids and lipoproteins
- Glycosphingolipid metabolism
|
|
|
|
|
|
ASCL1 and TCF4 |
achaete-scute family bHLH transcription factor 1 |
transcription factor 4 |
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
ASNS and WDR27 |
asparagine synthetase (glutamine-hydrolyzing) |
WD repeat domain 27 |
- Amino acid synthesis and interconversion (transamination)
- ATF4 activates genes
- PERK regulates gene expression
- Unfolded Protein Response (UPR)
- Metabolism of amino acids and derivatives
|
|
- L-Aspartic Acid
- L-Glutamic Acid
- Adenosine triphosphate
- L-Asparagine
|
|
|
|
GRAMD3 and FRMD8 |
GRAM domain containing 3 |
FERM domain containing 8 |
|
|
|
|
|
|
GRAMD3 and NAPRT |
GRAM domain containing 3 |
nicotinate phosphoribosyltransferase |
|
- Metabolism of vitamins and cofactors
- Defective CD320 causes methylmalonic aciduria
- Defective GIF causes intrinsic factor deficiency
- Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF
- Defective HLCS causes multiple carboxylase deficiency
- Defective MMAB causes methylmalonic aciduria type cblB
- Defective BTD causes biotidinase deficiency
- Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC
- Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD
- Defective MTR causes methylmalonic aciduria and homocystinuria type cblG
- Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE
- Defective MMAA causes methylmalonic aciduria type cblA
- Defective CUBN causes hereditary megaloblastic anemia 1
- Defective AMN causes hereditary megaloblastic anemia 1
- Defective MUT causes methylmalonic aciduria mut type
- Nicotinamide salvaging
- Metabolism of water-soluble vitamins and cofactors
- Defects in biotin (Btn) metabolism
- Defective TCN2 causes hereditary megaloblastic anemia
- Nicotinate metabolism
- Defects in cobalamin (B12) metabolism
- Defects in vitamin and cofactor metabolism
|
|
|
|
|
SEPHS1 and IGSF21 |
selenophosphate synthetase 1 |
immunoglobin superfamily, member 21 |
|
|
|
|
|
|
ATF3 and PDX1 |
activating transcription factor 3 |
pancreatic and duodenal homeobox 1 |
- ATF4 activates genes
- PERK regulates gene expression
- Unfolded Protein Response (UPR)
|
- Regulation of beta-cell development
- Regulation of gene expression in early pancreatic precursor cells
- Regulation of gene expression in beta cells
|
|
|
|
|